2016 annual financial data
Anika Therapeutics 2016 Net margin
Anika Therapeutics 2016 net margin with verified reported values.
Direct answer
Net margin was 31.48%.
Operating income was 50,607,000 USD and net income was 32,547,000 USD.
Operating cash flow was 23,801,000 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 103,379,000 USD
- Operating income
- 50,607,000 USD
- Net income
- 32,547,000 USD
- Operating cash flow
- 23,801,000 USD